Evaluation of the cellular immune responses induced by a non-adjuvanted inactivated whole virus A/H5N1/VN/1203 pandemic influenza vaccine in humans

Vaccine

Volumn 29, Issue 2, 2010, Pages 166-173

  Crowe, Brian A ^a   Brühl, Peter ^a   Gerencer, Marijan ^a   Schwendinger, Michael G ^a   Pilz, Andreas ^a   Kistner, Otfried ^a   Koelling Schlebusch, Katrin ^a   Aichinger, Gerald ^a   Singer, Julia ^a   Zeitlinger, Markus ^b   Müller, Markus ^b   Ehrlich, Hartmut ^a   Barrett, P Noel ^a  

^a BAXTER BIOSCIENCE   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Cellular immune response; Inactivated whole virus vaccine; Pandemic influenza

Indexed keywords

HEMAGGLUTININ; INFLUENZA VACCINE; INFLUENZA VIRUS A H5N1 VACCINE; UNCLASSIFIED DRUG;

ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS REACTION; DRUG SCREENING; HUMAN; INFLUENZA A (H3N2); INFLUENZA A (H5N1); INFLUENZA VACCINATION; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS A H5N1; MAJOR CLINICAL STUDY; MEMORY CELL; NONHUMAN; PANDEMIC INFLUENZA; PRIORITY JOURNAL; VERO CELL; VIRUS INACTIVATION; VIRUS STRAIN;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CERCOPITHECUS AETHIOPS; CROSS REACTIONS; HUMANS; IMMUNITY, CELLULAR; IMMUNIZATION, SECONDARY; IMMUNOLOGIC MEMORY; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MIDDLE AGED; PANDEMICS; VACCINATION; VACCINES, INACTIVATED; VERO CELLS; YOUNG ADULT;

EID: 78649698009     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.10.065     Document Type: Article

References (32)

1. Yamada S., Suzuki Y., Suzuki T., Le M.Q., Nidom C.A., Sakai-Tagawa Y., et al. Haemgglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors. Nature 2006, 444:378-382.
2. Ungchusak K., Auewarakul P., Dowell S.F., Kitphati R., Auwanit W., Outhavathana P., et al. Probable person-to-person transmission of avian influenza A (H5N1). N Engl J Med 2005, 352:333-340.
3. Yang Y., Halloran M.E., Sugimoto J.D., Longini I.M. Detecting human-to-human transmission of avian influenza A (H5N1). Emerg Infect Dis 2007, 13:1969-1971.
4. Kistner O., Howard M.K., Spruth M., Wodal W., Brühl P., Gerencer M., et al. Cell culture (Vero) derived whole virus (H5N1) vaccine based on wild-type virus strain induces cross-protective immune responses. Vaccine 2007, 25:6028-6036.
5. Howard M.K., Kistner O., Barrett P.N. Pre-clinical development of cell culture (Vero)-derived H5N1 pandemic vaccines. Biol Chem 2008, 389:569-577.
6. Ehrlich H.J., Müller M., Oh H.M., Tambyah P.A., Joukhadar C., Montomoli E., et al. A clinical trial of a whole-virus H5N1 vaccine derived from cell culture. N Engl J Med 2008, 358:2573-2584.
7. Ehrlich H.J., Müller M., Fritsch S., Zeitlinger M., Berezuk G., Löw-Baselli A., et al. A cell culture (Vero)-derived H5N1 whole-virus vaccine induces cross-reactive memory responses. J Infect Dis 2009, 200(October (7)):1113-1118.
8. Jelley-Gibbs D.M., Strutt T.M., McKinstry K.K., Swain S.L. Influencing the fates of CD4 T cells on a path to memory: lessons from influenza. Immunol Cell Biol 2008, 86:343-352.
9. Droebner K., Haasbach E., Fuchs C., Weinzierl A.O., Stevanovic S., Büttner M., et al. Antibodies and CD4(+) T-cells mediate cross-protection against H5N1 influenza virus infection in mice after vaccination with a low pathogenic H5N2 strain. Vaccine 2008, 26:6965-6974.
10. Dienz O., Eaton S.M., Bond J.P., Neveu W., Moquin D., Noubade R., et al. The induction of antibody production by IL-6 is indirectly mediated by IL-21 produced by CD4+ T cells. J Exp Med 2009, 206:69-78.
11. Castellini F., Germain R.N. Cooperation between CD4+ and CD8+ T cells: when, where, and how. Annu Rev Immunol 2006, 24:519-540.
12. Sant A.J., Chavez F.A., Krafcik F.R., Lazarski C.A., Menges P., Richards K., et al. Immunodominance in CD4 T-cell responses: implications for immune responses to influenza virus and for vaccine design. Expert Rev Vaccines 2007, 6:357-368.
13. Brown D.M., Roman E., Swain S.L. CD4 T cell responses to influenza infection. Semin Immunol 2004, 16:171-177.
14. Hobeika A.C., Morse M.A., Osada T., Ghanayem M., Niedzwiecki D., Barrier R., et al. Enumerating antigen-specific T-cell responses in peripheral blood: a comparison of peptide MHC Tetramer, ELISpot, and intracellular cytokine analysis. J Immunother 2005, 28:63-72.
15. Crotty S., Ahmed R. Immunological memory in humans. Semin Immunol 2004, 16:197-203.
16. Kelly D.F., Pollard A.J., Moxon E.R. Immunological memory: the role of B cells in long-term protection against invasive bacterial pathogens. JAMA 2005, 294:3019-3023.
17. Takahashi Y. Memory B cells in systemic and mucosal immune response: implications for successful vaccination. Biosci Biotechnol Biochem 2007, 71:2358-2366.
18. Crotty S., Aubert R.D., Glidewell J., Ahmed R. Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system. J Immunol Methods 2004, 286:111-122.
19. Powers D.C., Belshe R.B. Effect of age on cytotoxic T lymphocyte memory as well as serum and local antibody responses elicited by inactivated influenza virus vaccine. J Infect Dis 1993, 167:584-592.
20. Deng Y., Jing Y., Campbell A.E., Gravenstein S. Age-related impaired type 1 T cell responses to influenza: reduced activation ex vivo, decreased expansion in CTL culture in vitro, and blunted response to influenza vaccination in vivo in the elderly. J Immunol 2004, 172:3437-3446.
21. Disis M.L., dela Rosa C., Goodell V., Kuan L.Y., Chang J.C., Kuus-Reichel K., et al. Maximizing the retention of antigen specific lymphocyte function after cryopreservation. J Immunol Methods 2006, 308:13-18.
22. Dercamp C., Sanchez V., Barrier J., Trannoy E., Guy B. Depletion of human NK and CD8 cells prior to in vitro H1N1 flu vaccine stimulation increases the number of gamma interferon-secreting cells compared to the initial undepleted population in an ELISPOT assay. Clin Diagn Lab Immunol 2002, 9:230-235.
23. Lipatov A.S., Govorkova E.A., Webby R.J., Ozaki H., Peiris M., Guan Y., et al. Influenza: emergence and control. J Virol 2004, 78:8951-8959.
24. Horimoto T., Kawaoka Y. Influenza: lessons from past pandemics, warnings from current incidents. Nat Rev Microbiol 2005, 3:591-600.
25. Roti M., Yang J., Berger D., Huston L., James E.A., Kwok W.W. Healthy human subjects have CD4+ T cells directed against H5N1 influenza virus. J Immunol 2008, 180:1758-1768.
26. Lee L.Y., Ha do L.A., Simmons C., de Jong M.D., Chau N.V., Schumacher R., et al. Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals. J Clin Invest 2008 Oct, 118(10):3478-3490.
27. Goy K., Von Bibra S., Lewis J., Laurie K., Barr I., Anderson D., et al. Heterosubtypic T-cell responses against avian influenza H5 haemagglutinin are frequently detected in individuals vaccinated against or previously infected with human subtypes of influenza. Influenza Other Respir Viruses 2008, 2(July (4)):115-125.
28. Billiau A. Interferon-gamma: biology and role in pathogenesis. Adv Immunol 1996, 62:61-130.
29. Brown D.M., Dilzer A.M., Meents D.L., Swain S.L. CD4 T cell mediated protection from lethal influenza: perforin and antibody-mediated mechanisms give a one-two punch. J Immunol 2006, 177:2888-2898.
30. Aspinall R., Del Giudice G., Effros R.B., Grubeck-Loebenstein B., Sambhara S. Challenges for vaccination in the elderly. Immun Ageing 2007, 4:9.
31. Katz J.M., Plowden J., Renshaw-Hoelscher M., Lu X., Tumpey T.M., Sambhara S. Immunity to influenza: the challenges of protecting an aging population. Immunol Res 2004, 29:113-124.
32. Kang I., Hong M.S., Nolasco H., Park S.H., Dan J.M., Choi J.Y., et al. Age-associated change in the frequency of memory CD4+ T cells impairs long term CD4+ T cell responses to influenza vaccine. J Immunol 2004, 173:673-681.